About us

130 years of experience. Bold in research. Focused on one thing: improving lives through science.

Years of history
130
World distribution countries
40
Employees
950
R&D investment in 2024
+33%
Active clinical trials
10
Sales in USD millions (2024)
1,282

Science

With our research and development pipeline, we target some of the highest-needing therapeutic areas.

Nerve Growth Factor

In 2017, after seven years of challenging research, Dompé successfully engineered and manufactured the first recombinant human nerve growth factor (rhNGF).

Medicines

Our relentless drive to advance science and meet patients’ needs keeps us focused on what truly matters. With this commitment, we’re able to pioneer innovative treatments that transform lives—across ophthalmology, neurology and beyond.

Careers

Our values are the foundation that unites everything we do at Dompé. They express who we are as a company and guide our journey of following the science. We believe in the strength of these values to foster an inclusive culture—one where every individual feels respected, empowered, and motivated to drive innovation every day.